Laser or drops? new study tests best first move for glaucoma
NCT ID NCT07310719
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study compares two first-line treatments for primary open-angle glaucoma or high eye pressure: a one-time laser procedure (selective laser trabeculoplasty) versus daily latanoprost eye drops. Researchers will track how well each lowers eye pressure and note any side effects over three months. The goal is to see if the laser is a safe and effective alternative to daily drops for Nigerian patients.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Selective laser trabeculoplasty (laser procedure) and latanoprost eye drops
What this could lead to
If successful, this could show that a one-time laser procedure is as safe and effective as daily eye drops for controlling eye pressure in glaucoma patients.
What could go wrong
This is a small, short-term study (138 patients, 3 months) in a single hospital, so results may not apply broadly. The laser may not lower pressure enough, or side effects could differ from drops.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRIMARY OPEN ANGLE GLAUCOMA OR OCULAR HYPERTENSION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-••••
Locations
-
Lagos State University teaching Hospital Eye Institute
RECRUITINGIkeja, Lagos, Nigeria
Contact Phone: •••-•••-•••• Email: •••••@•••••